One of my acquaintances has no problem financially

New Post Public Reply Private Reply Replies (0) Message Board
joey68
One of my acquaintances has no problem financially investing in stocks over $50 a share.

That's 50 dollars for every share. Buying OWCP at only .16 cents isn't only considered pocket change; it's pocket lint; simply not worth it.

Think about that for a second. On one side of the market universe, most investors in these boards are only willing to buy shares in the pennies. On the other side are the whales. Big time investors able and willing to invest dollars per shares but ONLY once they see the price starting to climb.

I am personally convinced these whales are becoming more aware of OWCP every day. I am also personally convinced these big-time investors are waiting for the share price to reach $1 before creating huge positions worth hundreds of thousands of dollars.

Someone in the other board asked why doesn't one rich investor buy all the shares of OWCP right now? The thing is, this person isn't thinking like an investor. Yes, millionaires could easily buy every single penny stock share in every single penny stock company, and still have millions to spare.

So why don't they? Because its not worth it. Serious investors think differently than amateurs. Unlike amateur investors who buy shares of any 'promising' company, serious investors don't diversify. Instead they concentrate their efforts into just a few major plays.

Most importantly, serious 'whales' don't invest on their own. They have teams of people scouring for the best plays. And more often than not, the best plays are over $1.

Again, once OWCP reaches $1, I think it will be too late for the average investor to afford OWCP because by that time, the big boys will have taken over.

Not investment advice. Only invest what you can afford to lose.

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vanda Pharmaceuticals Steps Into September Investor Talks

Updated Category News Views 0

Vanda Pharmaceuticals Heads Into Key Investor Spotlights In the relentless quest for market edge, Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is setting the stage for what could be some telling moments in September 2026. Investors with a keen interest in the pharmaceutical realm should seat themselves upfront as Vanda takes the floor in a series of pivotal conferences. Each...

Continue Reading
Texas Institute Leads Trailblazing Arrhythmia Study

Updated Category News Views 2

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

Continue Reading
GenesisFX Rolls Out Live Leaderboards, Boosts Social Trading

Updated Category News Views 3

Traders buckle up! GenesisFX Markets just kicked open a new chapter in forex and CFD trading with their Live Leaderboards and beefed-up social trading tools. What's the commotion about? Well, that's your hook. These leaderboards are the newest addition to their ecosystem, paired with some serious social trading muscle. As Arkadiusz Bujalski, the Head of Ops and System...

Continue Reading
TCOM Secures $600M Deal to Boost NATO's Defense

Updated Category News Views 1

TCOM's Pivotal $600 Million Defense Contract How often do you hear about a deal north of $600 million that practically revamps a company's strategic future? That's precisely what's hitting the books at TCOM right now. They've scored a heavy-hitting Foreign Military Sales (FMS) contract to fortify NATO's eastern front with Poland. I'll tell you this—it’s one of the...

Continue Reading
Qingdao-Yerevan Collaboration: New Strategic Heights

Updated Category News Views 2

Qingdao and Yerevan: More Than Just a Port of Call Who would have thought? An Armenian ambassador talking shop in a Chinese port city isn't your everyday headline, but let me tell you, it's big news if you're watching global growth. Armenian Ambassador Vahe Gevorgyan's recent spiel in Qingdao might not turn heads on Wall Street, but there's more under the hood than meets...

Continue Reading
Crunch Fitness Organizes Major 9/11 Tribute Event

Updated Category News Views 0

A Climb for Remembrance In the realm of tributes that hit home, Fitness Ventures might have just nailed one. On this 25th anniversary of September 11, they're pulling no punches by bringing the gritty spirit of NYC right into the heart of 106 Crunch Fitness locations across America. You want to talk about a tribute that resonates, this is it—a Nationwide 9/11...

Continue Reading
ASUS Harnesses AI Power with ProArt RTX Spark PCs

Updated Category News Views 3

When ASUS throws its hat in the ring, you know it's going for the knockout. At IFA 2026, they're swinging for the fences with their new ProArt lineup—powered by NVIDIA RTX Spark. We're talking serious AI muscle here, up to 1 petaflop worth! What Makes This Lineup a Game Changer? The ProArt series, comprising of the P16 and P14 laptops, alongside the GR1X mini PC, is a...

Continue Reading
NEXA Unlimited: Disrupting Mortgage Broker Earnings

Updated Category News Views 7

What Exactly Is NEXA Unlimited? In a game-changer twist, NEXA Lending has launched something that could dramatically shuffle the current mortgage broker model deck. Dubbed NEXA Unlimited, this new model promises no less than 100% revenue access to its loan officers. We're talking zero fees—flat, funding, closing—none of ‘em. This isn't a small tweak or a cosmetic...

Continue Reading
Mito Health Achieves Milestone: A Million Lab Tests

Updated Category News Views 0

A Million Reasons to Take Note: Mito Health Expands If you've been snoozing on this, it's time to wake up. Mito Health just blew past a major milestone, hitting over one million lab tests since they set up shop in the diagnostics marketplace. That's no small potatoes for a company that's still fresh-faced since its 2023 debut in San Francisco. Revolutionizing Preventive...

Continue Reading
OCI Energy and Arava Power Ignite SunRoper Solar Project

Updated Category News Views 5

Bridging Houston's Energy Gap with New Solar Power There's a new player in town aiming to meet the growing electricity demand in the Houston area. On September 1, 2026, OCI Energy and Arava Power, along with their project partners, broke ground on the SunRoper Solar project in Wharton County, Texas. This isn't just any solar venture; it's a hefty 347 MWdc facility that's...

Continue Reading

Top 5 Most Recently Viewed Articles

Gershman Investment Corp. Secures Major Financing for Expansion

Updated Category News Views 242

Gershman Investment Corp. Secures FHA Financing for New Project Recently, Gershman Investment Corp. announced a significant financing deal, securing a substantial FHA 241(a) loan of $54.9 million to support the construction of a 300-unit addition to its existing apartment community. This ambitious project represents the commitment of Gershman Investment to enhance the...

Continue Reading
Stablecoins Revolution: Pioneering Changes in Financial Infrastructure

Updated Category News Views 162

Stablecoins Revolutionizing the Global Financial Landscape The stablecoin market is witnessing a pivotal transformation that promises to reshape the financial infrastructure as we know it. As detailed in a recent analysis, stablecoins have entered a new era filled with possibilities, particularly through their compliance, innovation, and heightened competition within the...

Continue Reading
Midas Immersion Cooling Enhances Energy Efficiency in the UK

Updated Category News Views 205

Midas Immersion Cooling Expands Its Operations in the UK Midas Immersion Cooling is making waves in the UK data center industry with the recent deployment of its innovative full-immersion cooling solution. This expansion reflects the company's ongoing commitment to providing cutting-edge, energy-efficient technologies to enhance performance for enterprises and hyperscale...

Continue Reading
Important Deadline for Spire Global, Inc. Shareholders Ahead

Updated Category News Views 40

Important Deadline for Spire Global, Inc. Investors For those who own shares of Spire Global, Inc. (NYSE: SPIR), there’s a crucial deadline approaching. Bernstein Liebhard LLP has put out a timely reminder for shareholders who may be affected by recent developments within the company. It’s essential for both current and former shareholders to understand their legal...

Continue Reading
Blumenthal Nordrehaug Bhowmik De Blouw LLP Takes Action Against Medata

Updated Category News Views 81

Class Action Filed Against Medata, Inc. Blumenthal Nordrehaug Bhowmik De Blouw LLP has stepped forward with a significant class action lawsuit against Medata, Inc. The firm alleges that Medata has not adhered to the California Labor Code, thus potentially affecting many employees' wages and rights. This legal action brings attention to crucial labor rights concerning meal...

Continue Reading